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Amyloid  P-component  (AP) 1 is  a  glycoprotein  found  in  all  forms of amyloid  in 
which  it  has  been  sought  (2-6),  including  primary  localized  cutaneous  amyloid 
deposits  (S.  Breathnach,  M.  M.  Black,  R.  F.  Dyck, and  M.  B.  Pepys. Unpublished 
observations.). It is probably derived from a  normal plasma protein, serum amyloid 
P-component (SAP), from which  it is indistinguishable  immunochemically in terms 
of polypeptide subunit size and composition, in electron microscopic appearance, and 
in  the  partial  amino acid sequence  that  is  presently available  (4,  5,  7-9).  SAP  has 
calcium-dependent binding affinity for a variety of ligands including isolated amyloid 
fibrils (10).  This interaction  may be involved in the deposition of AP in amyloid in 
vivo but  neither the role of AP in amyloidosis nor any other biological function  for 
SAP is known. 
AP was not originally detected in normal, non-amyloid-containing tissues (11), but 
more recently, Schneider and  Loos (12)  observed that  fluoresceinated anti-AP anti- 
bodies stained vascular and perivascular structures in sections of a number of normal 
tissues and suggested that AP may be a  form of type IV, basement-membrane-type 
collagen. We have confirmed their immunohistochemical findings and extended them 
with ultrastructural  studies and immunochemical and biochemical characterization 
of the AP-like molecule in glomerular basement membrane (GBM). This molecule is 
not immunochemically related to collagen but is apparently a normal matrix protein 
of GBM and possibly other vascular basement membranes. These observations may 
be significant in relation to both amyloidosis and other aspects of the pathophysiology 
of basement membranes. 
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Materials  and  Methods 
Antisera.  Monospecific antisera to human SAP and C-reactive protein (CRP) were raised 
by immunization of sheep and rabbits with the isolated pure proteins (8,  13). Monospecific 
rabbit anti-sheep IgG and sheep anti-human C3 were raised by immunization with sheep IgG 
isolated by salt fractionation and DEAE-cellulose chromatography and with human C3 isolated 
from fresh plasma (14), respectively. Fluoresceinated swine anti-rabbit IgG was obtained from 
Dakopatts A/S, Copenhagen, Denmark. The F(ab')2 fragments, prepared by pepsin digestion 
of the IgG fractions of rabbit anti-SAP and anti-CRP sera, were conjugated with fluorescein 
isothiocyanate (FITC; BDH  Chemicals Ltd., Poole, England) and, after chromatography on 
DEAE-ceilulose, fractions  with  OD  495/OD  280  <1.0  were  used  for  immunofluorescence 
staining  (15).  The  IgG1  fractions  of sheep  anti-SAP  and  anti-C3  were  conjugated  with 
horseradish  peroxidase  (HRP;  type VI;  Sigma Chemical  Co.  Ltd.,  Surrey,  England)  (16). 
Antisera to pepsin-solubilized collagens types I, III, IV, and V, isolated from human placenta, 
were  raised  in  rabbits  (17-19).  The  type  IV  collagen  had  been  further  purified  before 
immunization (20) and the purity of all types was assessed in sodium dodecyl sulphate (SDS; 
Sigma Chemical Co. Ltd.)-polyacrylamide  gel electrophoresis (PAGE) (21). Anti-human GBM 
antiserum was raised by immunization of a sheep with isolated lyophilized normal GBM (see 
below). 
Immunohistochemical Studies.  Cryostat sections were cut at 6-8 #m from snap-frozen blocks of 
normal  human  kidney, esophagus,  lung,  heart,  and  skin,  and  were  washed  in  phosphate- 
buffered saline, pH 7.4 (PBS) for 15 min at 21 °C. The sections were then stained with optimal 
dilutions of FITC-F(ab')2 anti-SAP for 30  min at  21°C, washed  three times with  PBS, and 
mounted  in  buffered  glycerol  for  examination  by  incident  light  fluorescence  in  a  Leitz 
Orthoplah  microscope  (E.  Leitz  Ltd.,  Luton,  England)  equipped  with  water  immersion 
objectives.  Control  sections  were  stained  with  FITC  anti-SAP  that  had  previously  been 
incubated with  10-100/tg of isolated pure SAP. A  further control was provided by staining 
with FITC-F(ab')2 anti-CRP, because CRP is very closely related structurally to SAP but is 
antigenically distinct (13, 22).  For indirect tests, sheep IgG anti-SAP or rabbit anti-type IV 
collagen were incubated on kidney sections for 30 min at 21°C, followed, after three washes in 
PBS, by the appropriate fluoresceinated anti-Ig reagents. Further incubation, washing, and 
mounting were then completed as described above. Controls included absorption of the anti- 
SAP reagent with isolated pure SAP before staining and substitution of normal sheep IgG or 
normal rabbit serum for the specific antibodies in the first layer of indirect tests. Kidney sections 
were also stained with HRP-anti-SAP or anti-C3 and  were processed for light and electron 
microscopy (23). 
To elute the AP-like material from GBM, separate cryostat sections of normal kidney were 
incubated for 30 rain at 21°C in the following reagents: PBS (control); 0.01  M  EDTA-0.01 M 
Tris-0.14 M  NaCI, pH 8.0;  2.0  M  NaC1;  0.01  M  EDTA-2.0  M  NaCI; 0.1  M  dithiothreitol 
(DTT;  Sigma Chemical Co. Ltd.)-0.01  M  EDTA-0.01  M  Tris-0.14 M  NaC1, pH 8.0;  0.1  M 
DTT-0.01  M  EDTA-2.0  M  NaCI;  1%  (vol:vol) Triton  X-100  (BDH)  in  PBS;  1%  (vol:vol) 
Nonidet P-40  (Sigma Chemical Co.)  in  PBS;  1%  (vol:vol) Triton X-100-0.1  M  DTT-2.0  M 
NaCI-0.01 M EDTA; 0.1% (wt:vol) SDS-0.1 M DTT-PBS; 2.0 M hydroxylammonium chloride, 
pH  10.5. Other sections were incubated for  16 h at 37°C in 0.1  M  DTT-2.0 M  NaCI-0.01 M 
EDTA and for 5 h at 37°C in 6.0 M  guanidine hydrochloride (Sigma Chemical Co. Ltd.)-0.5 
M  Tris-0.1 M  DTT-0.001  M  EDTA, pH 8.5. After these various incubations, the sections were 
all washed three times in PBS and then stained with FITC-F(ab')2 anti-SAP. 
Preparation of  Human GBM.  GBM was isolated (24) from normal kidneys removed at autopsy 
and  stored at  -20°C.  90-95%  of the  final  product  had  the  appearance of GBM  by  light 
microscopy. Lyophilized GBM was suspended at 25  mg/ml in 0.1  M  Tris-0.005  M  calcium 
acetate, pH 7.4, and stirred continuously during incubation at 37°C with 0.7% wt:wt bacterial 
collagenase. In pilot experiments, samples of the mixture were removed and centrifuged after 
30, 60, 90,  120, 180, and 360 min, and after 19 h incubation. Digestion of collagen was assessed 
by assay of hydroxyproline released into the supernate (25), and release of AP-like material was 
measured by electroimmunoassay (see below). Collagenase was obtained from Sigma Chemical 
Co. Ltd.: type I  (crude) and type VI (purified, free of nonspecific proteinase, clostripain, and 
tryptic activity), and type I was also used after purification to yield isolated collagenase (26). 1164  AMYLOID P-COMPONENT  IN  BASEMENT MEMBRANE 
Immunochemical  Studies.  The collagenase-solubilized  GBM was tested by double immunodif- 
fusion in gel against sheep anti-SAP and anti-GBM sera, in comparison with isolated pure SAP 
and normal human serum. It was also run in electroimmunoassay (27) against anti-SAP and 
polyvalent anti-normal human serum, and in crossed immunoelectrophoresis (28) against anti- 
SAP.  1% wt:vol agarose gel  (Indubiose A37; L'Industrie Biologique Francaise S. A., Clichy, 
France)  in 0.07  M  barbitone-0.01 M  EDTA,  pH  8.6  was  used  in all  these  tests.  Isolated 
lyophilized GBM  and the  insoluble residue after the  19-h  digestion with collagenase were 
washed with PBS and then incubated for 30 min at 21°C with FITC-F(ab')2  anti-SAP. Control 
samples were  treated with FITC-anti-SAP that  had  previously been absorbed with isolated 
SAP.  The insoluble GBM  was  then washed  three  times  in PBS  and mounted in buffered 
glycerol for fluorescence microscopy. Cross-reactivity  between anti-SAP serum and anti-collagen 
serum was sought by passive  hemagglutination testing (29). Tanned sheep erythrocytes were 
coated with isolated collagen types I, III, IV, and V, and their agglutination by anti-SAP was 
compared with that produced by a mixture of antisera specific for those collagen types. Rabbit 
anti-type IV collagen was also tested by gel immunodiffusion  for reactivity with normal human 
serum and isolated SAP. 
Biochemical  Studies.  GBM  solubilized by  collagenase was  radiolabeled  with  carrier-free 
Na[t25I] (IMS 30; Radiochemical Centre, Amersham, England) by the Iodogen (Pierce Chem- 
ical Co.,  Rockford,  Ill.)  method  (30). Protein-bound 125I was  separated  from labeled small 
peptides and free 12hi on Sephadex G-25 in PBS. The labeled protein had a  77.5/~Ci/A~0 sp 
act. 
Normal human serum, isolated SAP, and x25I-GBM were subjected to isoelectric  focusing in 
agarose gel over a  pH 3.5-0.5 range with the reagents, Multiphor apparatus, and procedure 
provided by LKB Instruments Ltd., London, England. The gel was then immunofixed (31) 
with sheep anti-SAP serum, washed, dried, and subjected to radioautography with LKB aH- 
Ultrofilm. 
Some of the lzSI-GBM was also coprecipitated with an optimal-proportions mixture, deter- 
mined by previous titration, of isolated SAP and sheep anti-SAP serum. The mixture was 
incubated for 45  min at  37°C and then at 4°C for  16 h, after which, it was centrifuged at 
10,000 g for 5 min, and the precipitate washed twice in PBS.  A control coprecipitation was 
performed simultaneously under identical conditions with isolated CRP and sheep anti-CRP 
serum. The precipitates were dissolved  by heating at  100°C for 5 min in 2% wt:vol SDS, 5% 
vol:vol mercaptoethanol (Sigma Chemical Co.  Ltd.), 0.06 M  Tris-HCl, pH 6.8, and run in a 
12% slab SDS-PAGE (32). Samples of unlabeled collagenase-solubilized  GBM, 125I-GBM, pure 
SAP, and pure CRP were run on the same gel under reducing conditions, as well as marker 
proteins of defined molecular weight (obtained from Pharmacia G. B. Ltd., London, England): 
rabbit muscle phosphorylase b, subunit 94,000 mol wt; bovine serum albumin, 67,000 mol wt; 
hen ovalbumin,  43,000 mol wt; bovine erythrocyte carbonic anhydrase, 30,000 mol wt; soybean 
trypsin inhibitor, 20,100 moi wt; bovine a-lactalbumin, 14,000 mol wt. After electrophoresis, 
the gel was  fixed,  stained with 0.2% Coomassie blue (BDH), dried, and an autoradiograph 
prepared using LKB ~H-Uhrofilm. In a  further experiment,  1.5 ml of I~SI-GBM was  mixed 
with 3.5 ml of 0.01 M  Tris-0.14 M  NaCI-0.01  M  EDTA, pH 8.0 and ehromatographed on a 
2.6- ×  90-cm column of Sephacryi S-300 (Pharmaeia) equilibrated with the same buffer. The 
sample was eluted at 16 ml/h and fractions of 5.8 ml were collected; 100 #1 of each was counted 
in a Packard 5210 y-scintillation  counter (Packard Instrument Co.,  Downers Grove, Ill.)  and 
then coprecipitated with an optimal-proportions mixture of SAP and anti-SAP. After  1 h at 
37°C and then  16 h  at 4°C, these precipitates were  washed  with Tris-EDTA and counted 
again to determine the proportion of total radioactivity per fraction attributable to anti-SAP- 
reactive material. A sample of isolated SAP was mixed with a  1:5 dilution of normal human 
serum, heated at 60°C for 30  min to mimic the collagenase inactivation step in the GBM 
solubilization procedure, and was  then run on the same Sephaeryl column under identical 
conditions to the ~25I-GBM.  SAP was quantitated in the eluted fractions by electroimmunoassay. 
The column was calibrated using samples of dextran blue 2000 and marker proteins of known 
molecular weight. DYCK ET AL.  1165 
Results 
Immunohistochemical Localization of AP in Normal Human Tissues.  With  direct  and 
indirect immunofluorescence and immunoperoxidase techniques on sections of  normal 
kidney, rabbit and sheep anti-SAP antibodies produced linear staining of glomerular 
capillaries and structures in the walls of small arterioles (Fig.  1). The immunological 
specificity of this staining was established by its complete inhibition when the anti- 
SAP reagents were absorbed with microgram quantities of isolated pure SAP before 
application to the tissue sections (Fig.  1). Anti-CRP antibodies did not stain normal 
kidney tissue at all, nor was there staining in indirect tests in which normal rabbit or 
sheep sera were substituted  for anti-SAP.  Electron microscopy of glomeruli stained 
with  HRP-sheep  IgG  anti-SAP  revealed  a  homogeneous  linear  band  of staining 
confined to the endothelial side, the lamina tara interna, of the GBM  (Fig.  2).  No 
staining was observed in control sections treated with HRP-sheep IgG anti-C3. 
FITC-F(ab')2 anti-SAP also stained alveolar capillary walls in sections of normal 
lung and linear intercellular structures in both cardiac and smooth muscle. In sections 
of skin,  anti-SAP  stained  the  capillary  loops  around  the  rete  ridges  but  not  the 
basement membrane at the dermo-epidermal junction. 
To characterize the nature of the association of the AP-like material with GBM, 
attempts were made to elute it from sections of kidney. There was no change in uptake 
of anti-SAP after sections had been incubated in EDTA, 2.0 M  NaCl, EDTA-2.0 M 
NaCI,  DTT-EDTA,  DT-I'-EDTA-2.0 M  NaC1,  SDS,  Triton X-100,  Nonidet  P-40, 
Triton X  I00-DTT-EDTA-2.0 M  NaCI, or hydroxylamine. However treatment with 
SDS-DTT  or  with  6.0  M  guanidine-DTT-EDTA,  both  of which  solubilized  the 
glomeruli, abolished staining. 
Lack of lmmunological Cross-Reactivity between SAP and Collagen.  Rabbit anti-type IV 
collagen antiserum stained both GBM and tubular basement membrane with equal 
intensity, producing a quite different pattern from that seen in kidney sections stained 
with anti-SAP. Furthermore, anti-SAP serum did not agglutinate sheep erythrocytes 
coated with isolated collagen types (Table I), nor did anti-type IV collagen precipitate 
in gel with SAP. 
Digestion of Isolated GBM by Collagenase.  Lyophilized GBM isolated from normal 
kidneys  and  suspended  in  PBS  stained  immunospecifically with  FITC-anti-SAP. 
When GBM was digested with bacterial collagenase, part of it was solubilized, and 
the supernate contained an antigen that precipitated in gel with anti-SAP serum (Fig. 
3). There was no difference in the rate at which GBM was digested by crude type I 
collagenase, purified type I collagenase, or pure type VI collagenase, as measured by 
release of hydroxyproline or by the appearance into solution of the AP-like antigen. 
The concentration of anti-SAP reactive material in the supernate reached a maximum 
after 30-60 min. digestion and in some experiments its concentration decreased after 
2  h.  Therefore,  for  further  characterization  of the  AP-like  material,  GBM  was 
incubated  for 45  min  with  purified  type I  collagenase, after which,  the supernate 
derived from 25 mg GBM/ml had an A~0 of 10-15. Some insoluble residue always 
remained and this still stained specifically with FITC-anti-SAP. 
Immunochemical Studies of the AP-like Material from GBM.  After digestion of GBM 
with collagenase, as described above, the supernate contained an antigen that gave a 
precipitation line in gel of complete identity with that between anti-SAP and normal 
serum or isolated pure SAP  (Fig.  3).  Sheep anti-GBM serum  reacted with normal Ftc,  1.  Normal human kidney stained with FITC-anti-SAP, Linear staining of glomerular capil- 
lary walls (A) and specific inhibition of  staining (B) when the fluoresceinated antibody was absorbed 
with pure SAP. ×  400. 
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Fro, 2.  Electronmicrograph of normal human giomerulus stained with HRP-anti-SAP. CL, cap- 
illary lumen. The arrows indicate the continuous line of black peroxidase reaction product in the 
lamina rara interna of the GBM. X 2,250. 
TABLE I 
Passive Hemagglutination Assay for Cross-Reaction between  Antisera to 
Collagen and to SAP 
Antigen 
Haemagglutination titer 
Polyvalent  Anti-SAP 
anti-collagen 
-log2 
Control uncoated cells  2  2 
Type I collagen  6  1 
Type III collagen  6  2 
Type IV collagen  7  2 
Type V collagen  6  1 
human  serum  and  with  pure  SAP;  in  both  cases,  the  precipitation  line  identified 
completely with that produced by sheep anti-SAP (Fig. 3). Although immunochemi- 
cally  indistinguishable  from  SAP,  the  AP-like  material  in  solubilized  GBM  was 
heterogeneous  in electrophoretic  mobility,  a  significant  proportion of the molecules 
were more anodal than SAP in crossed immunoelectrophoresis (Fig. 4). This produced 
a  differently shaped rocket of immunoprecipitation  in the electroimmunoassay  (Fig. 
4) so that precise quantitation  of the amount of antigen present by comparison with 
normal serum standards was not possible. 1168  AMYLOID P-COMPONENT  IN BASEMENT  MEMBRANE 
FIG. 3.  Immunodiffusion  in  agarose gel between collagenase-solubilized GBM,  normal human 
serum (HS, NHS), isolated SAP and antisera against SAP (aSAP), and GBM (0tGBM). 
Flo.  4.  (A) Crossed immunoelectrophoresis of collagenase-solubitized GBM and normal human 
serum (NHS) agaifist anti-SAP serum. (B) Electroimmunoassay of NHS and collagenase-solubilized 
GBM with anti-SAP serum. 
Approximate estimates of the concentration of AP-like antigen in different prepa- 
rations of solubilized GBM  lay between  40  and  90/Lg/ml,  whereas  ~120  #g/ml  of 
serum albumin was present. Polyvalent sheep anti-normal human serum also detected 
traces of two other serum proteins in the solubilized GBM. 
Biochemical Characterization of the AP-like Material  from GBM.  After isoelectric focus- 
ing of 125I-GBM, immunofixation with anti-SAP revealed a  broad series of bands over 
a  pH 3.9-4.8 range that overlapped, but was more anodal, than the isoelectric points 
(pI) of pure SAP or SAP in serum.  Radioiodinated protein that coprecipitated from 
lzSI-GBM with complexes of SAP and anti-SAP was run on a  12%  slab SDS-PAGE 
under reducing conditions. Some labeled material failed to enter the gel, indicating 
that it was of high molecular weight (>250,000), but two main bands and two fainter 
ones were seen (Fig. 5). One major band migrated to almost the same position as the 
subunit  of isolated SAP. The other major band  lay between ovalbumin and  bovine 
serum albumin standards. The subunits of SAP and CRP  are known to migrate with 
anomalously large apparent molecular weights in SDS-PAGE (33). When the calibra- ,
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tion curve for log molecular weight versus Rf, obtained with standard marker proteins, 
was  corrected  for  the  known  molecular  weights  of CRP  and  SAP  (33,  34),  the 
apparent  sizes of the  two main  labeled chains  from the AP-like molecule in  GBM 
were 24,000 and 46,000 tool wt, respectively. The control coprecipitate of 125I-GBM 
with complexes of CRP and anti-CRP did not contain any labeled material demon- 
strable by radioautography after they were run on the SDS-PAGE. 
Most  of the  material  with  an  A2~  in  the  tzSI-GBM  preparation  eluted  from  a 
Sephacryl S-300 column in the void volume, and most of the labeled material that 
was  specifically  precipitated  by  anti-SAP  was  also  in  this  fraction,  suggesting  a 
>750,000 tool wt (Fig. 6). However, a second peak of AP-like protein eluted from the 
column in the same volume as SAP in normal human serum (235,000 tool wt) run as 
a  standard  (Fig.  6).  Approximately  10%  of  the  total  activity  in  the  125I-GBM 
preparation was specifically immunoprecipitated with SAP-anti-SAP complexes. 
Discussion 
Our findings demonstrate that normal human GBM, and, probably, other vascular 
basement membranes, contain a  protein that is immunochemically indistinguishable 
from AP. In electron microscopic studies of glomeruli, this material was confined to 
the lamina rara interna of the basement membranek In collagenase-solubilized GBM, 
there were comparable amounts of the AP-like antigen and of serum albumin, which 
contrasts with  their relative plasma concentrations  of 1,000:1  in  favor of albumin, 
and suggests that  SAP  is  not just  nonspecifically absorbed onto GBM.  The AP  in 
GBM was not held there via noncovalent intermolecular interactions or via the known 
calcium-dependent ligand binding of SAP and AP, because it could not be eluted by 
high-ionic-strength salt, EDTA, or either polar or nonpolar detergents. It was also not 
eluted  by reduction  of disulphide  bridges  alone  (with  DTT)  or by treatment  with 
hydroxylamine. These observations suggest that it may be covalently linked as one of 
the normal matrix glycoproteins of GBM. 
The AP-like antigen may be associated with the collagen moiety of GBM because 
5- 
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Fro.  6.  Gel filtration of t25I-GBM on Sephacryl S-300.  Vo, void volume estimated with dextran 
blue 2000;  Vt, column volume; Ve, eluted volume; SAP  designates the elution  volume of SAP 
subsequently run on the same column. DYCK ET AL.  1171 
it was  released into solution when GBM was  digested  by pure collagenase free of 
neutral proteinase, clostripain, and  tryptic activity. Although it gave precipitation 
lines  of identity with  SAP,  the  antigen  from  GBM was  heterogeneous in  pI  and 
electrophoretic mobility and much of it was of high molecular weight (>750,000 tool 
wt). However some did have the same apparent molecular weight, 235,000, as SAP. 
Studies of the polypeptide chain structure in SDS-PAGE also suggested that  there 
were some subunits marginally larger (24,000 tool wt) than those of SAP (23,500 mol 
wt), whereas others were approximately twofold larger (46,000 mol wt) and a  major 
portion were >250,000 mol wt. Taken in conjunction, these observations indicate that 
the AP-like protein in GBM is very similar to SAP, but is covalently linked to other 
components of GBM. When released into solution by the action of collagenase, most, 
or even all, the AP subunits are still associated with other peptide chain fragments 
that are possibly derived from collagen or other matrix proteins. It is not possible now 
to estimate precisely the amount of AP in GBM, but it is probably more than a trace 
component, because ~ 10% of the radioactivity in the iodinated collagenase-solubilized 
GBM was specifically precipitated by anti-SAP. 
The source of AP in basement membrane is not known, but it is of interest that 
such closely related proteins should be present both in the circulation and in basement 
membranes. One possibility is that the basement membrane AP derives from plasma 
SAP  and  is  incorporated  into  nascent  basement  membrane as  it  is  laid  down  or 
becomes covalently linked to already established basement membrane. Alternatively, 
the basement membrane AP may be produced locally by vascular endothelial cells or 
fibroblasts.  It  has  been  reported  that  human  fibroblasts cultured  in  vitro  in  the 
absence of human serum can be stained with anti-AP antibodies (35), but this has not 
been confirmed, nor was it possible to demonstrate incorporation of radioactive amino 
acids into SAP in such cultures despite unequivocal demonstration of de novo synthesis 
of Clq at the same time (M. B. Pepys and K. Reid. Unpublished observations.). On 
the  other  hand,  circulating  SAP  levels  are  low  in  patients  with  hepatocellular 
insufficiency (36) and the liver is the site of SAP synthesis in the mouse (37). 
The presence of AP in normal basement membranes raises a number of intriguing 
possibilities.  In the first place, vascular basement  membranes  are among the most 
important  filters between  the  intra-  and  extravascular compartments  both  in  the 
kidney  and  elsewhere.  Although  there  is  as  yet  no  direct  evidence  regarding  a 
physiological role for AP in this respect, it is known that the net negative charge on 
the glomerular capillary wall, derived in part  from anionic matrix glycoproteins of 
the GBM, is necessary for integrity of the filtration barrier (38). AP could thus be a 
target for various pathological processes that affect basement membrane, and we have 
recently observed distinctive abnormal patterns in the disposition of AP in GBM of 
patients  with  membranous glomerulonephritis, acute post-infectious nephritis,  and 
diabetic  glomerulosclerosis,  z  Secondly, GBM  is  one of the  earliest  sites  at  which 
amyloid fibrils are deposited (39).  Because AP is present in amyloid deposits both in 
man  and  experimental animals  (37, 40)  and  SAP binds  to amyloid fibrils in  vitro 
(10),  it  is  conceivable that  basement  membrane AP  contributes to  localization of 
fibrils in  this site. Thirdly, SAP has calcium-dependent binding affinity for as yet 
Dyck, R. F., D. J. Evans, C. M. la~kwood, A. Rees, D. Turner, and M. B. Pepys. 1980. Amyloid P- 
component in human glomerular  basement membrane: abnormal patterns of immunofluorescent  staining 
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unidentified  ligands in agarose (8,  13),  other galactans  (41), some microbial polysac- 
charides  (10) and also a  modified form of the complement component C3fl If the AP 
within basement membranes expresses this binding capacity in vivo, it could provide 
a  mechanism whereby circulating ligands could localize and focus immunological or 
other inflammatory processes onto basement  membrane. 
Summary 
Glomerular  and  other  vascular  basement  membranes  were  found  to  contain  an 
antigen  that  was  immunochemically indistinguishable  from serum  amyloid  P-com- 
ponent.  There  was  no  immunological  cross-reactivity  between  antisera  to  serum 
amyloid P-component and to collagen types I, III, IV, or V. The amyloid P-component 
antigen was confined to the endothelial aspect, the lamina rara interna, of glomerular 
basement  membrane.  It  could  not  be  eluted  by high-ionic-strength  saline,  EDTA, 
dithiothreitol,  or either  polar or nonpolar detergents,  but  was released  into solution 
when  isolated  glomerular  basement  membrane  was  digested  by  highly  purified 
bacterial  collagenase.  Most  of these  P-component  molecules  and  their  constituent 
polypeptide chains were of higher molecular weight and lower isoelectric point than 
serum amyloid P-component. These findings indicate that, as well as being a  normal 
plasma protein and a  universal constituent  of amyloid deposits,  P-component is also 
a normal matrix glycoprotein of basement membrane in which it is covalently linked 
to collagen and/or other matrix proteins. This may be relevant both to the pathogen- 
esis  of amyloidosis  and  to  other  aspects  of physiology and  pathology of basement 
membranes. 
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